MedPath

XIAFLEX

XIAFLEX

Discontinued
DIN Number

02388316

Drug Class

Human

Market Date

Nov 14, 2012

Company
HC

Endo Operations Ltd.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02388316
AIG Number0153188001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
M09AB02 COLLAGENASE CLOSTRIDIUM HISTOLYTICUM
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntralesional
AHFS Classification44:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

COLLAGENASE CLOSTRIDIUM HISTOLYTICUMActive
Strength: 0.9 MG / VIAL
Monograph: COLLAGENASE CLOSTRIDIUM HISTOLYTICUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.